| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |